Special Announcement
MARK H. KAPLAN
APPOINTED AS NEXT EDITOR-IN-CHIEF OF IMMUNOHORIZONS
The American Association of Immunologists (AAI) is pleased to announce the appointment of Mark H. Kaplan, Ph.D., as the incoming Editor-in-Chief (EIC) of ImmunoHorizons (IH). IH is an open access, fully peer-reviewed journal owned and published by AAI. Dr. Kaplan will serve a 3-year term from January 1, 2020, through December 31, 2022.
Dr. Kaplan was recently named the Nicole Brown Chair of the Department of Microbiology and Immunology at Indiana University School of Medicine. He was also named the Director of Basic Science at the Brown Center for Immunotherapy. Both positions start in 2020.
Dr. Kaplan, an AAI member since 1998, served as an Associate Editor of The Journal of Immunology (The JI) from 2003 to 2007 and as a Section Editor from 2007 to 2011. He then served as a Senior Editor of IH from 2017 to 2019. He has also served on the Abstract Programming Committee for the AAI annual meetings from 2014 to 2017.
Dr. Kaplan received an Honours B.Sc. in Biology from the University of Windsor, Ontario, Canada, and a Ph.D. in Immunology and Microbiology from Wayne State University. He did postdoctoral work at the University of Texas Southwestern Medical Center and at the Harvard University School of Public Health. He joined the faculty at the Indiana University School of Medicine in 1998 as an Assistant Professor of Microbiology and Immunology. In 2005, he moved to the Department of Pediatrics to become the Director of Pediatric Pulmonary Basic Research. He was promoted to professor and subsequently honored with the Billie Lou Wood Professorship. In 2017, Dr. Kaplan was named as associate director of the HB Wells Center for Pediatric Research. He will leave these positions when he assumes the Nicole Brown Chair appointment in 2020.
Dr. Kaplan’s research focuses on understanding the function of transcription factors in the development of T helper cell subsets. He has a long-standing interest in signal transduction and activation of transcription (STAT) proteins that are activated downstream of cytokines. His more recent work focuses on understanding how T cell subsets contribute to allergic and autoimmune inflammation, specifically, on understanding the development and function of IL-9-secreting T cells in inflammatory disease.
Dr. Kaplan joined an outstanding field of applicants for the EIC position. The Call for Applications for the position was announced on June 12, 2019, and applications were accepted through August 30, 2019. Interviews were carried out by the AAI Publications Committee which made a recommendation to the AAI Council. Upon acceptance of the position, Dr. Kaplan stated, “I am honored to have both been considered and selected for the position. I am excited to build on the foundation that Drs. Berg and Krangel built, and I look forward to further establishing ImmunoHorizons as a destination for high-quality immunology research.”
Dr. Kaplan succeeds co-Editors-in-Chief Leslie J. Berg, Ph.D., and Michael S. Krangel, Ph.D., who served as the inaugural editors of ImmunoHorizons.
Members of the AAI Council, Publications Committee, and staff join the membership in congratulating Dr. Kaplan on his appointment and look forward to his leadership.
ImmunoHorizons (IH) is published by the American Association of Immunologists and is a fully peer-reviewed open access, online-only journal committed to advancing the knowledge of immunology. Criteria for publication include rigorous methodology with well supported conclusions that advance the field and are of broad interest. ImmunoHorizons will consider observations of interest even if complete mechanistic or functional characterization cannot yet be provided. ImmunoHorizons will also consider for publication novel methods, assays or computational tools, as well as initial characterizations of novel reagents, including mouse strains, clones and antibodies, even if biological insights have not yet been fully realized. Large descriptive data sets which are of interest to the field will also be considered.
In November 2018, ImmunoHorizons was selected for inclusion in MEDLINE after a rigorous evaluation by the Literature Selection Technical Review Committee (LSTRC) of the National Library of Medicine (NLM). Only 12-15% of journals are recommended for inclusion in MEDLINE, which is considered to be the most comprehensive index of medical scientific journal articles. This NLM premier bibliographic database contains more than 25 million references to journal articles in life sciences with a concentration on biomedicine.
For more information on ImmunoHorizons, please visit ImmunoHorizons.org.